[go: up one dir, main page]

ZA200607603B - Controlled-release pharmaceutical composition and method for producing the same - Google Patents

Controlled-release pharmaceutical composition and method for producing the same Download PDF

Info

Publication number
ZA200607603B
ZA200607603B ZA200607603A ZA200607603A ZA200607603B ZA 200607603 B ZA200607603 B ZA 200607603B ZA 200607603 A ZA200607603 A ZA 200607603A ZA 200607603 A ZA200607603 A ZA 200607603A ZA 200607603 B ZA200607603 B ZA 200607603B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
release
controlled
coating
release pharmaceutical
Prior art date
Application number
ZA200607603A
Other languages
English (en)
Inventor
Yoshitake Takashi
Moroshima Kenji
Mizuno Mitsuru
Aoki Shigeru
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of ZA200607603B publication Critical patent/ZA200607603B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
ZA200607603A 2004-03-26 2006-09-11 Controlled-release pharmaceutical composition and method for producing the same ZA200607603B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004093506 2004-03-26

Publications (1)

Publication Number Publication Date
ZA200607603B true ZA200607603B (en) 2007-05-30

Family

ID=35055974

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200607603A ZA200607603B (en) 2004-03-26 2006-09-11 Controlled-release pharmaceutical composition and method for producing the same

Country Status (17)

Country Link
US (2) US20080095839A1 (ja)
EP (1) EP1728512A1 (ja)
JP (1) JPWO2005092336A1 (ja)
KR (1) KR100794078B1 (ja)
CN (1) CN1938026A (ja)
AU (1) AU2005225283B2 (ja)
BR (1) BRPI0509135A (ja)
CA (1) CA2557791C (ja)
IL (1) IL177087A (ja)
MX (1) MXPA06010785A (ja)
MY (1) MY139427A (ja)
NO (1) NO20064874L (ja)
NZ (1) NZ549838A (ja)
RU (1) RU2337687C2 (ja)
TW (1) TW200602085A (ja)
WO (1) WO2005092336A1 (ja)
ZA (1) ZA200607603B (ja)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050163846A1 (en) * 2001-11-21 2005-07-28 Eisai Co., Ltd. Preparation composition containing acid-unstable physiologically active compound, and process for producing same
BRPI0509135A (pt) * 2004-03-26 2007-08-28 Eisai R&D Man Co Ltd composição farmacêutica de liberação controlada e método para produzir a mesma
CA2570916C (en) 2004-06-16 2013-06-11 Tap Pharmaceutical Products, Inc. Pulsed release dosage form of a ppi
NZ555693A (en) 2004-12-27 2010-10-29 Eisai R&D Man Co Ltd Matrix type sustained-release preparation containing donepezil
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
EP1930030A1 (en) * 2005-09-29 2008-06-11 Eisai R&D Management Co., Ltd. Pulse preparation having improved disintegration properties in vivo
EP1872778A1 (en) * 2006-06-29 2008-01-02 LEK Pharmaceuticals D.D. Stable pharmaceutical composition with rabeprazole sodium
DE102006035549A1 (de) 2006-07-27 2008-01-31 Evonik Röhm Gmbh Arzneiform mit mindestens zweischichtiger Trennschicht
WO2008015530A2 (en) * 2006-08-03 2008-02-07 Aurobindo Pharma Limited Stable solid oral formulation of pantoprazole
WO2008062320A2 (en) 2006-10-06 2008-05-29 Eisai R&D Management Co., Ltd Extended release formulations of a proton pump inhibitor
PL2187873T3 (pl) 2007-08-13 2019-01-31 Abuse Deterrent Pharmaceutical Llc Leki odporne na nadużywanie, metoda stosowania i metoda wytwarzania
JP2009191036A (ja) * 2008-02-15 2009-08-27 Ss Pharmaceut Co Ltd 時限放出製剤
JP4864024B2 (ja) * 2008-02-15 2012-01-25 エスエス製薬株式会社 時限放出製剤
JP2009191034A (ja) * 2008-02-15 2009-08-27 Ss Pharmaceut Co Ltd 時限放出製剤
EP2255794A1 (en) * 2009-05-29 2010-12-01 H e x a l Aktiengesellschaft Enteric coating
JP5503192B2 (ja) * 2009-06-03 2014-05-28 大原薬品工業株式会社 生理活性物質含有粒子の製造方法
KR20120047243A (ko) * 2009-07-30 2012-05-11 에보니크 룀 게엠베하 음이온 중합체 물질 및 6 내지 22 개의 탄소 원자를 가지는 포화 모노카르복실산의 염을 포함하는 조성물
US8962020B2 (en) * 2012-07-26 2015-02-24 Glycadia Inc. Long-acting and controlled release formulations of 2-[(3-chlorophenyl) amino] phenylacetic acid
JP2014122328A (ja) * 2012-11-22 2014-07-03 Shin Etsu Chem Co Ltd 押出成形機又は射出成形機洗浄用組成物及び押出成形機又は射出成形機の洗浄方法
US20140275149A1 (en) 2013-03-15 2014-09-18 Inspirion Delivery Technologies, Llc Abuse deterrent compositions and methods of use
CN103976972B (zh) * 2014-05-26 2017-09-12 中国药科大学 酒石酸唑吡坦口服脉冲控释给药系统及其制备方法
US10729685B2 (en) 2014-09-15 2020-08-04 Ohemo Life Sciences Inc. Orally administrable compositions and methods of deterring abuse by intranasal administration
PL3324948T3 (pl) 2015-07-17 2023-06-26 BE Pharbel Manufacturing Wielowarstwowe mikrocząstki uwalniające związek farmaceutycznie aktywny w płynnej postaci dawkowania
US12472149B2 (en) 2015-07-17 2025-11-18 BE Pharbel Manufacturing Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form
EP3117824A1 (en) 2015-07-17 2017-01-18 BE Pharbel Manufacturing Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form
CN105796532B (zh) * 2016-03-28 2018-12-21 中国医药集团总公司四川抗菌素工业研究所 一种雷贝拉唑钠缓释胶囊及其制备方法
AU2019383389A1 (en) * 2018-11-19 2021-05-06 Jazz Pharmaceuticals Ireland Limited Alcohol-resistant drug formulations
KR102810679B1 (ko) * 2019-12-06 2025-05-20 진양제약주식회사 제약 조성물
JP7624444B2 (ja) * 2019-12-11 2025-01-30 エボニック オペレーションズ ゲーエムベーハー 病気の治療又は予防において使用するための剤形
TW202139986A (zh) 2020-02-21 2021-11-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 治療原發性嗜睡症之方法
CN113069428B (zh) * 2021-04-02 2023-02-10 珠海润都制药股份有限公司 一种雷贝拉唑钠肠溶片的制备方法
KR102647279B1 (ko) 2021-04-08 2024-03-18 대한뉴팜(주) 라베프라졸의 우수한 방출 특성을 갖는 라베프라졸 나트륨 및 산화마그네슘을 포함하는 제제 및 이의 제조방법

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
US4863744A (en) * 1984-09-17 1989-09-05 Alza Corporation Intestine drug delivery
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
JPH0768125B2 (ja) * 1988-05-18 1995-07-26 エーザイ株式会社 酸不安定化合物の内服用製剤
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
US5229131A (en) * 1990-02-05 1993-07-20 University Of Michigan Pulsatile drug delivery system
KR930006431B1 (ko) * 1990-10-11 1993-07-16 재단법인 한국화학연구소 약물의 미세캡슐화 방법
YU48263B (sh) * 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
US5260068A (en) * 1992-05-04 1993-11-09 Anda Sr Pharmaceuticals Inc. Multiparticulate pulsatile drug delivery system
FR2692146B1 (fr) * 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
US6156343A (en) * 1994-12-27 2000-12-05 Akzo Nobel N.V. Controlled release preparation
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
ES2137862B1 (es) * 1997-07-31 2000-09-16 Intexim S A Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
US6296876B1 (en) * 1997-10-06 2001-10-02 Isa Odidi Pharmaceutical formulations for acid labile substances
SE9704870D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
ES2559766T3 (es) * 1998-05-18 2016-02-15 Takeda Pharmaceutical Company Limited Comprimidos disgregables en la boca
JP2000128779A (ja) * 1998-10-20 2000-05-09 Mitsui Chemicals Inc 薬物放出制御型製剤
SE9803772D0 (sv) * 1998-11-05 1998-11-05 Astra Ab Pharmaceutical formulation
US6183766B1 (en) * 1999-02-12 2001-02-06 The Procter & Gamble Company Skin sanitizing compositions
US6174902B1 (en) * 1999-04-28 2001-01-16 Sepracor Inc. R-rabeprazole compositions and methods
JP2001055322A (ja) * 1999-08-18 2001-02-27 Tanabe Seiyaku Co Ltd パルス放出型製剤
US6369087B1 (en) * 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
TWI268779B (en) * 1999-10-20 2006-12-21 Eisai Co Ltd Method for stabilizing benzimidazole-based compounds
US6627223B2 (en) * 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems
US20020045184A1 (en) * 2000-10-02 2002-04-18 Chih-Ming Chen Packaging system
US20050163846A1 (en) * 2001-11-21 2005-07-28 Eisai Co., Ltd. Preparation composition containing acid-unstable physiologically active compound, and process for producing same
EP1454634A4 (en) * 2001-11-21 2007-05-30 Eisai R&D Man Co Ltd PREPARATIONS WITH SAVER ELABILES PHYSIOLOGICALLY ACTIVE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
AU2002258002A1 (en) * 2002-04-29 2003-11-17 Egis Gyogyszergyar Rt A process for the preparation of tablets from pharmaceutically active substances having unfavourable tabletting properties with a granulating liquid comprising microcrystalline cellulose
CN1964704A (zh) * 2004-03-03 2007-05-16 特瓦制药工业有限公司 包含酸不稳定药物的稳定药用组合物
BRPI0509135A (pt) * 2004-03-26 2007-08-28 Eisai R&D Man Co Ltd composição farmacêutica de liberação controlada e método para produzir a mesma
EP1930030A1 (en) * 2005-09-29 2008-06-11 Eisai R&D Management Co., Ltd. Pulse preparation having improved disintegration properties in vivo

Also Published As

Publication number Publication date
AU2005225283B2 (en) 2008-09-18
JPWO2005092336A1 (ja) 2008-02-07
AU2005225283A1 (en) 2005-10-06
TW200602085A (en) 2006-01-16
BRPI0509135A (pt) 2007-08-28
US20070110806A1 (en) 2007-05-17
WO2005092336A1 (ja) 2005-10-06
NO20064874L (no) 2006-12-19
US20080095839A1 (en) 2008-04-24
US20120003311A9 (en) 2012-01-05
EP1728512A1 (en) 2006-12-06
MY139427A (en) 2009-09-30
CN1938026A (zh) 2007-03-28
MXPA06010785A (es) 2007-03-28
IL177087A (en) 2011-11-30
IL177087A0 (en) 2006-12-10
KR20060134124A (ko) 2006-12-27
CA2557791C (en) 2011-03-08
KR100794078B1 (ko) 2008-01-10
CA2557791A1 (en) 2005-10-06
NZ549838A (en) 2010-04-30
RU2006134052A (ru) 2008-04-10
RU2337687C2 (ru) 2008-11-10

Similar Documents

Publication Publication Date Title
CA2557791C (en) Controlled-release pharmaceutical composition and method for producing the same
RU2095054C1 (ru) Твердая лекарственная форма для орального введения
EP1715856B1 (en) Atomoxetine formulations
US20050158383A1 (en) Quetiapine formulations
US20040213847A1 (en) Delayed release pharmaceutical compositions containing proton pump inhibitors
BG65008B1 (bg) Орална лекарствена дозирана форма с импулсно освобождаване
EP1703898A2 (en) Ziprasidone formulations
CA2539982A1 (en) Pantoprazole multiparticulate formulations
CA2702356A1 (en) Pharmaceutical formulation comprising a proton pump inhibitor for the treatment of gastrointestinal conditions independent of food intake
RU2311906C2 (ru) Композиция препарата замедленного высвобождения для высвобождения ингибитора секреции кислоты в желудке и способ ее получения
US20070141137A1 (en) Stable capsule preparation
KR20160021095A (ko) 탐술로신 또는 이의 염의 약학 조성물
JP7541617B2 (ja) 腸溶性ペレット及びその製造方法並びにそれを含む製剤
EP1930030A1 (en) Pulse preparation having improved disintegration properties in vivo
CA2536902A1 (en) Proton pump inhibitor formulations, and methods of preparing and using such formulations
HK1100805A (en) Controlled-leaching preparation and process for producing the same
US20220249479A1 (en) Modified release formulation of a pyrimidinylamino-pyrazole compound, and methods of treatment
JP2000502066A (ja) 徐放性シサプリド
RU2821366C1 (ru) Пеллеты с энтеросолюбильным покрытием, способ их получения и содержащие их составы
HK1103623A (en) Controlled-leaching preparation and process for producing the same
WO2008062320A2 (en) Extended release formulations of a proton pump inhibitor
CA2558783A1 (en) Oral morphine multiparticulate formulation
HK1120736A (en) Pulse preparation having improved disintegration properties in vivo